Inhaled corticosteroids in COPD: friend or foe?

Alvar Agusti; Leonardo M. Fabbri; Dave Singh; Jorgen Vestbo; Bartolome Celli; Frits M. E. Franssen; Klaus F. Rabe; Alberto Papi

doi:10.1183/13993003.01219-2018

Inhaled corticosteroids in COPD: friend or foe?

Alvar Agusti, Leonardo M. Fabbri, Dave Singh, Jorgen Vestbo, Bartolome Celli, Frits M. E. Franssen, Klaus F. Rabe, Alberto Papi

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Article number	1801219
Number of pages	14
Journal	European Respiratory Journal
Volume	52
Issue number	6
DOIs	https://doi.org/10.1183/13993003.01219-2018
Publication status	Published - 1 Dec 2018

Keywords

OBSTRUCTIVE PULMONARY-DISEASE
FLUTICASONE PROPIONATE/SALMETEROL 250/50
COMMUNITY-ACQUIRED PNEUMONIA
BLOOD EOSINOPHIL COUNT
AIR-FLOW LIMITATION
POST-HOC ANALYSIS
DOUBLE-BLIND
LUNG-FUNCTION
TRIPLE THERAPY
PARALLEL-GROUP

Cite this

Agusti, A., Fabbri, L. M., Singh, D., Vestbo, J., Celli, B., Franssen, F. M. E., Rabe, K. F., & Papi, A. (2018). Inhaled corticosteroids in COPD: friend or foe? European Respiratory Journal, 52(6), [1801219]. https://doi.org/10.1183/13993003.01219-2018

@article{872c53e99f37417db73920ad9c9580dc,

title = "Inhaled corticosteroids in COPD: friend or foe?",

keywords = "OBSTRUCTIVE PULMONARY-DISEASE, FLUTICASONE PROPIONATE/SALMETEROL 250/50, COMMUNITY-ACQUIRED PNEUMONIA, BLOOD EOSINOPHIL COUNT, AIR-FLOW LIMITATION, POST-HOC ANALYSIS, DOUBLE-BLIND, LUNG-FUNCTION, TRIPLE THERAPY, PARALLEL-GROUP",

author = "Alvar Agusti and Fabbri, {Leonardo M.} and Dave Singh and Jorgen Vestbo and Bartolome Celli and Franssen, {Frits M. E.} and Rabe, {Klaus F.} and Alberto Papi",

year = "2018",

month = dec,

day = "1",

doi = "10.1183/13993003.01219-2018",

language = "English",

volume = "52",

journal = "European Respiratory Journal",

issn = "0903-1936",